指南与共识胸部肿瘤放疗放疗物理与技术

美国退伍军人事务部放射肿瘤学质量监督项目与ASTRO专家小组制定的肺癌共识质量指标和剂量约束

Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel.
指南 / 共识 · Pract Radiat Oncol · 2023-04-18

美国退伍军人事务部国家放射肿瘤学项目与ASTRO合作,于2022年由肺癌专家蓝带小组更新共识质量指标和剂量体积直方图约束。共制定19项肺癌质量指标和121项DVH约束,涵盖超低分次、低分次和常规分次方案,将用于退伍军人质量监督。

要点

  • 共制定19项肺癌质量指标,覆盖初诊检查、模拟计划实施和随访三阶段。
  • 针对超低分次(1、3、4、5次)、低分次(10、15次)和常规分次(30–35次)制定121项DVH约束。
  • 指标将用于VA系统内外退伍军人的质量监督,并作为肺癌特异性质量指标资源。

核心结论

  • 制定的措施将用于VA系统内外退伍军人的质量监督,并为肺癌特异性质量指标提供资源。
  • 推荐的DVH约束作为跨多种分次方案的循证和专家共识约束的独特综合资源。

研究设计与样本

  • 由肺癌专家蓝带小组与ASTRO于2022年共同审查并制定一系列措施和性能标准。
  • 针对初诊检查、模拟治疗计划实施和随访开发质量、监督和理想指标,并审查定义靶区和危及器官的DVH约束。

主要发现

  • 共开发19项肺癌质量指标。
  • 针对超低分次(1、3、4或5次)、低分次(10和15次)和常规分次(30–35次)开发121项DVH约束。

关键数值与推荐

  • 质量指标涵盖初诊检查、模拟治疗计划实施和随访三部分。
  • DVH约束覆盖超低分次1、3、4、5次,低分次10、15次,常规分次30–35次方案。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: For patients with lung cancer, it is critical to provide evidence-based radiation therapy to ensure high-quality care. The US Department of Veterans Affairs (VA) National Radiation Oncology Program partnered with the American Society for Radiation Oncology (ASTRO) as part of the VA Radiation Oncology Quality Surveillance to develop lung cancer quality metrics and assess quality of care as a pilot program in 2016. This article presents recently updated consensus quality measures and dose-volume histogram (DVH) constraints. METHODS AND MATERIALS: A series of measures and performance standards were reviewed and developed by a Blue-Ribbon Panel of lung cancer experts in conjunction with ASTRO in 2022. As part of this initiative, quality, surveillance, and aspirational metrics were developed for (1) initial consultation and workup; (2) simulation, treatment planning, and treatment delivery; and (3) follow-up. The DVH metrics for target and organ-at-risk treatment planning dose constraints were also reviewed and defined. RESULTS: Altogether, a total of 19 lung cancer quality metrics were developed. There were 121 DVH constraints developed for various fractionation regimens, including ultrahypofractionated (1, 3, 4, or 5 fractions), hypofractionated (10 and 15 fractionations), and conventional fractionation (30-35 fractions). CONCLUSIONS: The devised measures will be implemented for quality surveillance for veterans both inside and outside of the VA system and will provide a resource for lung cancer-specific quality metrics. The recommended DVH constraints serve as a unique, comprehensive resource for evidence- and expert consensus-based constraints across multiple fractionation schemas.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Puckett LL, Titi M, Kujundzic K, et al. Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel. Pract Radiat Oncol. 2023. PMID: 37075838. doi:10.1016/j.prro.2023.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。